The continuous hormone monitoring market is expected to grow from USD 325.7 million in 2025 to USD 716.2 million by 2035, at a CAGR of 8.2%. Urine samples are projected to dominate the market with an 81% share, while fertility applications are anticipated to lead at 65%.